Cardinal Health (NYSE:CAH) Upgraded at Argus

Argus upgraded shares of Cardinal Health (NYSE:CAH) to a strong-buy rating in a research report sent to investors on Thursday,Zacks.com reports.

A number of other equities research analysts also recently issued reports on CAH. Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $190.00 to $244.00 in a research report on Friday, January 9th. Mizuho set a $222.00 price target on Cardinal Health in a report on Monday, January 12th. Deutsche Bank Aktiengesellschaft lifted their price target on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research report on Tuesday, November 18th. Robert W. Baird set a $250.00 price objective on shares of Cardinal Health in a research report on Wednesday, January 14th. Finally, UBS Group lifted their target price on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Fourteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $221.07.

Cardinal Health Stock Up 0.7%

Shares of CAH opened at $208.29 on Thursday. The business’s 50-day moving average price is $205.78 and its 200-day moving average price is $176.26. The stock has a market cap of $49.49 billion, a PE ratio of 31.42, a P/E/G ratio of 1.41 and a beta of 0.65. Cardinal Health has a twelve month low of $120.72 and a twelve month high of $215.48.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter in the prior year, the firm posted $1.88 EPS. Cardinal Health’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Analysts expect that Cardinal Health will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Friday, January 2nd. Cardinal Health’s payout ratio is presently 30.77%.

Hedge Funds Weigh In On Cardinal Health

A number of large investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC boosted its position in Cardinal Health by 25.8% during the fourth quarter. Farther Finance Advisors LLC now owns 14,487 shares of the company’s stock valued at $2,977,000 after buying an additional 2,973 shares during the period. Sage Mountain Advisors LLC lifted its stake in shares of Cardinal Health by 11.0% in the 4th quarter. Sage Mountain Advisors LLC now owns 2,991 shares of the company’s stock valued at $615,000 after acquiring an additional 296 shares during the last quarter. Freestone Capital Holdings LLC boosted its holdings in Cardinal Health by 3.7% during the 4th quarter. Freestone Capital Holdings LLC now owns 59,049 shares of the company’s stock valued at $12,135,000 after acquiring an additional 2,092 shares during the period. Cura Wealth Advisors LLC bought a new position in Cardinal Health during the 4th quarter worth approximately $227,000. Finally, Assetmark Inc. increased its stake in Cardinal Health by 14.4% in the 4th quarter. Assetmark Inc. now owns 78,139 shares of the company’s stock worth $16,058,000 after purchasing an additional 9,823 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.